simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 44;5^{th}-Individual ID 44;5^{th}-Individual ID 44;5^{th}-Individual ID 44;5^{th}-Individual ID 44;;;95^{th}-Individual ID 23;95^{th}-Individual ID 23;95^{th}-Individual ID 23;95^{th}-Individual ID 23;95^{th}-Individual ID 23
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.728164041716887;-0.189774675694228;-0.434010725040269;-0.572504866803845;0.564433849411181;;;-0.563157264408187;-0.139123044356709;-0.485320406411984;-0.603259189705959;0.97683557412657
;-0.745295785825245;-0.255671233148928;-0.457118418105406;-0.617478623898735;0.484002710861953;;;-0.603759265861968;-0.15971404555712;-0.512414714267556;-0.65143004649113;0.974162042251157
;-0.711032297608529;-0.123878118239529;-0.410903031975132;-0.527531109708956;0.644864987960409;;;-0.522555262954406;-0.118532043156297;-0.458226098556412;-0.555088332920789;0.979509106001982
;0.99983606466101;0.965516777249296;0.999161029232717;0.998175407335177;0.994021158435451;;;0.998462672408456;0.993553158749706;0.999077646618959;0.998114873661737;0.999997781160342
;8.90879773263557e-07;0.00274634022311649;1.03161690559606e-05;3.3096010177199e-05;0.000196560028896993;;;2.55940439529403e-05;0.000220115878592401;1.18920053169679e-05;3.47572449500951e-05;1.40274274866396e-09
